betamethasone has been researched along with metoclopramide in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (27.27) | 18.7374 |
1990's | 2 (9.09) | 18.2507 |
2000's | 7 (31.82) | 29.6817 |
2010's | 6 (27.27) | 24.3611 |
2020's | 1 (4.55) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Busnardo, B; Casara, D; De Besi, P; Fiorentino, MV; Girelli, ME; Nacamulli, D; Simioni, N; Toso, S; Zorat, P | 1 |
Hallén, C; Sorbe, B | 3 |
Ikubo, A; Miyazaki, K | 1 |
Kagami, Y; Narimatsu, N; Nishio, M; Sakurai, T; Tomita, M | 1 |
Hallén, C; Skåre, NG; Sorbe, B; Underskog, I | 1 |
Hatae, Y; Hatayama, Y; Kishino, T; Nakadate, H; Ogawa, Y; Takeda, T | 1 |
Axelsson, P; Lövqvist, A; Thörn, SE; Wattwil, L; Wattwil, M | 1 |
Eksborg, S; Lönnqvist, PA; Öbrink, E; Oddby-Muhrbeck, E; Rotstein, S | 1 |
Avillach, P; Bauer-Mehren, A; Boyer, S; Coloma, PM; Furlong, L; Gini, R; Helgee, EA; Herings, R; Kors, J; Matthews, J; Mazzaglia, G; Mestres, J; Molokhia, M; Oliveira, JL; Pedersen, L; Picelli, G; Prieto-Merino, D; Sanz, F; Schuemie, MJ; Scotti, L; Sturkenboom, M; Trifirò, G; van der Lei, J; van Mulligen, E | 1 |
Date, Y; Fujimura, Y; Inoue, H; Kihira, Y; Kojima, E; Kumagai, T; Narahara, N; Ogawa, S; Sato, E; Tsuruta, Y; Yoshitomi, H | 1 |
5 trial(s) available for betamethasone and metoclopramide
Article | Year |
---|---|
Betamethasone-dixyrazine versus betamethasone-metoclopramide as antiemetic treatment of cisplatin-doxorubicin-induced nausea in ovarian carcinoma patients.
Topics: Activities of Daily Living; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Metoclopramide; Nausea; Ovarian Neoplasms; Phenothiazines; Pilot Projects; Prospective Studies; Random Allocation; Vomiting | 1991 |
Antiemetic treatment of chemotherapy-induced nausea in ovarian carcinoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Betamethasone; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Humans; Melphalan; Metoclopramide; Nausea; Ovarian Neoplasms; Phenothiazines; Prospective Studies; Random Allocation | 1989 |
Betamethasone-dixyrazine combination versus high-dose metoclopramide as antiemetic treatment in doxorubicin and cisplatin chemotherapy.
Topics: Antiemetics; Betamethasone; Cisplatin; Double-Blind Method; Doxorubicin; Female; Humans; Male; Metoclopramide; Middle Aged; Phenothiazines; Prospective Studies; Random Allocation; Vomiting | 1989 |
Betamethasone-dixyrazine versus metoclopramide as antiemetic treatment in cancer chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Betamethasone; Clinical Trials as Topic; Double-Blind Method; Humans; Metoclopramide; Nausea; Neoplasms; Phenothiazines; Prospective Studies; Random Allocation; Vomiting | 1988 |
Betamethasone does not prevent nausea and vomiting induced by the dopamine-agonist apomorphine.
Topics: Adult; Apomorphine; Betamethasone; Dopamine Agonists; Dopamine Antagonists; Female; Glucocorticoids; Humans; Male; Metoclopramide; Nausea; Pain Measurement; Reference Values; Severity of Illness Index; Time Factors; Treatment Outcome; Vasopressins; Vomiting | 2006 |
17 other study(ies) available for betamethasone and metoclopramide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer.
Topics: Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Bleomycin; Carcinoma; Carmustine; Cisplatin; Doxorubicin; Female; Fluorouracil; Humans; Male; Methotrexate; Metoclopramide; Middle Aged; Nausea; Thyroid Neoplasms; Vincristine | 1991 |
[A case report of bilateral liver metastasis from rectal cancer effectively treated with continuous infusion of anti-cancer drugs through hepatic artery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mannitol; Metoclopramide; Middle Aged; Mitomycin; Mitomycins; Rectal Neoplasms | 1989 |
[Antiemetic efficacy of betamethasone versus betamethasone combined with metoclopramide in cisplatin-treated cancer patients].
Topics: Adult; Aged; Antiemetics; Betamethasone; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Metoclopramide; Middle Aged; Neoplasms; Vomiting | 1989 |
[The antiemetic effect and clinical evaluation of metoclopramide alone and combined with betamethasone in children with malignant tumor].
Topics: Adolescent; Adrenal Cortex; Antineoplastic Agents; Betamethasone; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Male; Metoclopramide; Nausea; Neoplasms; Vomiting | 1989 |
Is there an association between PONV and chemotherapy-induced nausea and vomiting?
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease Resistance; Droperidol; Epirubicin; Female; Fluorouracil; Granisetron; Humans; Mastectomy; Methotrexate; Metoclopramide; Middle Aged; Models, Biological; Narcotics; Nausea; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Risk Factors; Vomiting | 2013 |
Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system.
Topics: Acute Disease; Adverse Drug Reaction Reporting Systems; Azithromycin; Betamethasone; Cisapride; Domperidone; Electronic Health Records; Fluconazole; Humans; Megestrol Acetate; Metoclopramide; Myocardial Infarction | 2013 |
[Stability of Six Drugs in Total Parenteral Nutrition Solution].
Topics: Betamethasone; Bromhexine; Butylscopolammonium Bromide; Drug Packaging; Drug Stability; Famotidine; Furosemide; Metoclopramide; Parenteral Nutrition Solutions; Parenteral Nutrition, Home Total | 2021 |